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 ABSTRACT 
In the experiments made on white rats was studied the influence of 
coptisine bisulfate, alkaloid extracted from Chelidonium majus, in the 
following doses: 10 mg/kg and 20 mg/kg on acute toxic hepatitis cause 
by carbon tetrachloride. It was established that the researched substance 
reduced hepatic cytolysis and cholestasis through reestablishment of the 
transaminases activity and lactate dehydrogenase, while lowering the 
alkaline phosphatase/alanine aminotransferase ratio and modulated the 
deflection of the metabolic parameters of acute toxic hepatitis. Coptisine 
bisulfate corrected the carbon tetrachloride caused hypoproteinemia 
when administered for 7 days and normalized the albumin level at 14th 
day of treatment of acute toxic hepatitis. 
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Introduction. Hepatoprotective activity of Chelidonium majus shows benefic influence on the 
liver functions due to isoquinoline derivatives with antioxidant, choleretic, anti inflammatory and 
immunomodulatory effects, one of them being coptisine [2, 5]. Chelidonium majus ethanolic extract 
proved the capacity of reducing the hepatotoxicity induced by carbon tetrachloride, through lowering 
the lipids cumulation, celular necrosis grouth and the lack of [6]. 
A certain amount of clinical studies that contain extracts from the patients with biliary tract 
and gallbladder disorders (gallstones, cholecystitis, cholangitis, postcholecystectomy syndrome, 
alcoholic toxic hepatitis) sugested a significant improvement of the clinical, instrumental and 
laboratory parameters (bilirubin, transaminases, complete blood count) [6].  
Coptisine bisulfate, presented at the Medicine Scientific Centre, USMF ”Nicolae Testemițanu” 
[1] was obtained from Celandine herbs.  
Scientific literature analisis allow us to conclude that extract and alkaloids of Chelidonium 
majus manifests hepatoprotective activity through:  decreasing the production of the reactive species 
of Oxygen; inhibition of the lipids peroxidation; glutathione synthesis rise and antioxidant enzyme 
activity; reduction of the inflammatory process due to decreasing of proinflammatory cytokines 
production; correction of lipidic metabolism disorders.  
Due to the lack of coptisine bisulfate toxicity [3, 4], compared with berberin and other 
alkaloids of Chelidonium majus and considering the hepatoprotective effect, it was established the aim 
of experimental research of coptisine bisulfate on acute toxic hepatitis (ATH) shaped in white rats by 
administering carbon tetrachloride. 
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Results. Using coptisine bisulfate in the treatment of ATH, there were studied the influence of 
this alkaloid on the evolution of acute hepatic lesion when using 10 and 20 mg/kg strenghts for 
establishing a strengh- hepatoprotective effect dependency.   
When shaping ATH using CCl4  at the 7th day it was observed a growing of AlAT from  
56,8±2,4 mmol/l to  190,6±8,2 mmol/l (P1-2<0,05) and AsAT – from  140,2±5,0 mmol/l to 260,2±20,5 
mmol/l (P<0,05). This growing of the transaminase level is still manifesting after 2 weeks after the 
hepatotoxic was administered (tab.1). In these condition were determined a reduction of Ritis 
coefficient from 2,46±0,21 to 1,36±0,25. Coptisine bisuflate administration in 10 mg/kg and 20 mg/kg 
strenghts for 7 and 14 days contributed to maintaining of AlAT and AsAT levels and Ritis coefficient, 
basically at the position of witness lot (tab. 1).  
Tabel 1. Modification of transaminase level in serum in carbon tetrachloride induced HT and 
coptisine bisulfate 10 and 20 mg/kg usage 








1. Witness lot 10 56,8±2,4 140,2±5,0 2,46±0,21 







































































When injected CCl4 at the 7th day it was determined a growth of alkaline phosphatase activity 
from 510,2±23,3 UI/l in the witness lot to 1063,7±57,5 UI/l (P<0,05). When using coptisine bisulfate 
in doses 10 mg/kg and 20 mg/kg for 7 days there was noticed a decreased level of alkaline 
phosphatase level comparing with the ATH lot, which was non significantly higher than the witness 
lot. When shaping the experimental hepatitis at 14th day it was noticed that alkaline phosphatase 
content was 784,4±62,7 UI/l  compared to 510,2±23,3 UI/l (P<0,05) in the witness lot, but lower than 
CCl4  lot at 7th day - 784,4±62,7 UI/l  compared to 1063,7±57,5 UI/l (P<0,05). When coptisine 
bisulfate was administered in both doses there were no esential changes to the lot with CCl4 after14 
days determined (tab. 2).  
When ATH was shaped at the 7th day was determined a decreasing of the acidic phosphatase 
from 4,8±0,3 UI/l in the witness lot to 3,7±0,3 UI/l (P<0,05), which was maintained at the same level 
at 14th day as well. When coptisine bisulfate was administered for 7 days in the doses 10 mg/kg and 
20 mg/kg it was established a significant reduction of the acidic phosphatase level in the witness lot, 
and in the experimental hepatitis one as well. When the alkaloid was used for 2 weeks in both 
strenghts the acidic phosphatase content increased from 3,7±0,3 UI/l in the lot with CCl4 to 4,2±0,4 
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Tabel 2. The modification of alkaline phosphatase activity, acidic phosphatase and  GGTP in 
serum in carbon tetrachloride induced HT and the coptisine bisulfate 10 and 20 mg/kg usage 









1. The witness lot 7 510,2±23,3 4,8±0,3 3,7±0,4 







































































In ATH, induced by CCl4, activity of GGTP did not change significantly at the 7th day, but 
increased a lot at the 14th day (tab. 2). When coptisine bisulfate was administered in the dose of 10 
mg/kg  the level of the enzyme increased from 3,6±0,3  UI/l in the lot with CCl4, to 4,3±0,7 UI/l (P> 
0,05), while the alkaloid in the dose of 20 mg/kg was decreasing snonsignificantly the content of 
GGTP (tab. 2). The usage of the alkaloid for 2 weeks contributed to diminishing of the GGTP level 
from 6,7±0,7 UI/l int he lost with experimental hepatitis, to 4,1±0,4 UI/l and 4,2±0,5 UI/l (P<0,05) in 
doses of 10 mg/kg and 20 mg/kg accordingly. 
In the process of shaping the experimental hepatitis at the 7th day there was noticed a 
tendency of growing the bilirubin total level in rats from 40,1±2,6 mmol/l to 44,2±3,6 mmol/l 
(P>0,05), direct bilirubin from 23,0±1,4 mmol/k to 26,3±2,7 mmol/l (P>0,05) and indirect bilirubin 
from  17,1±1,3 mmol/l to 17,9±1,6 mmol/l  (P>0,05). When coptisine bisulfate was administered in 
the doses of10 mg/kg and 20 mg/kg for 7 days there were no main changes in the total bilirubin 
content and its fractions (tab. 3). After 14 days there were no significant diversion in total, direct and 
indirect bilirubin level in comparison with the witness lot, in animals with ATH. Coptisine bisulfate, 
used for 2 weeks, both strenghts, did not influence the content of bilirubin and its fractions (tab. 3). 
Tabel 3. The modification of the total, direct and indirect bilirubin level in serum in carbon 
tetrachloride induced HT and coptisine bisulfate 10 and 20 mg/kg usage 











1 2 3 4 5 
1. The witness lot 7 40,1±2,6 23,0±1,4 17,1±1,3 
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Continuation of table 3 
1 2 3 4 5 





























When determining the LDH level at the 7th day after shaping ATH it was determined a growth 
of LDH from 386,2±12,8 UI/l in the witness lot to 1005,7±72,5 UI/l (P1-2<0,05), following to grow until 
1355,7±83,7 UI/l (P<0,05) in the 14th day. Whencoptisine bisulfate in strenghts of 10mg/kg and 
20mg/kg was administered for 7 and 14 days, the LDH level was at the position of the animals in the 
witness lot (tab. 4). 
When shaping ATH it was noticed a non esential fall of the glucose level in the 7th day and a 
non significant increase in the 14th day. Coptisine bisulfate, in 10 mg/kg and 20 mg/kg doses, nearly 
did not influence after 1 week and after 2 weeks as well, the changes of blood glucose induced by the 
hepatotoxic substance (tab. 4). 
Tabel 4. The modification of LDH activity, glucose level and thymol reaction in carbon 
tetrachloride induced HT and coptisine bisulfate 10 and 20 mg/kg usage 









1. The witness lot 7 386,2±12,8 5,2±0,3 4,17±0,1 








































































Carbon tetrachloride did not influence the cholesterol total level in the 7th day, but determined 
a increase of it in the 14th day from 5,09±0,04 mmol/l in the witness lot to 5,28±0,05 mmol/l 
(P<0,05).  Coptisine bisulfate (10 mg/kg and 20 mg/kg), administered for 7 and 14 days determined a 
decrease of the total cholesterol content (tab. 5).   
In the experimental hepatitis were not ascertained esential changes of the total protein level, 
both in 7th and 14th day (tab. 5). In the same time the hepatotoxic determined a decrease of the 
albumin content from 5,28±0,05 g/l in the witness lot to 30,6±0,8 g/l (P<0,05).  Coptisine bisulfate in 
doses of 10 mg/kg and 20 mg/kg, when administered for 7 days, corrected the CCl4 induced 
hypoproteinemia. The albumin level in the 14th day in animals with ATH and the ones treated with 
coptisine bisulfate was at the level of the witness lot  (tab. 5). 
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Tabel 5. The modification of the cholesterol level, total proteins and albumin in serum in 
carbon tetrachloride induced HT and coptisine bisulfate 10 and 20 mg/kg usage 








1. The witness lot 7 5,09±0,04 58,3±0,5 35,5±0,8 








































































According to the obtained results, coptisine bisulfate, one of Chelidonium majus  alkaloids is a 
component that lacks in systemic toxicity, owns hepatoprotective properties through re- establishing 
the transaminases activity, reducing the Ritis coefficient and normalizing the cholestasis in acute toxic 
hepatitis induced by carbon tetrachloride. This fact indicates its contribution to pharmacological 
effects of celandine extracts and the possibility of using of this product in the complex treatment of 
toxic hepatitis. 
Conclusions. 
1. Coptisine bisulfate, in doses of 10 mg/kg and 20 mg/kg, in a dose dependent way, 
annihilated the cytolisis syndrome by reestablishing the transaminases activity, esspecially ALAT, and 
the obvious decrease of the Ritis ratio.  
2. It was established the reduction of cholestasis under the influence of coptisine bisulfate by 
non esential growth of alkaline phosphatase activity and of total, direct and indirect bilirubin level, 
(decrease of FA/ALAT ratio) and modulated the metabolic parameters deflection of acute toxic 
hepatitis. 
3. When administered for 7 and 14 days, coptisine bisulfate in strenghts of 10 mg/kg and 20 
mg/kg, normalises the LDH content at the level or witness lot animals, but the blood glucose level 
induced by the hepatotoxic substance was not influenced. 
4. Coptisine bisulfate corrected the hypoproteinemia caused by CCl4 , when administered for 
7 days and normalised the albumin level in the 14th day of treatment of the ATH animals.  
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